Search     Contact 
     Members Sign-in 
ABOUT BAYBIOGET INVOLVEDEVENT CENTERMEMBER CENTERINFORMATION CENTER







MEDIA CENTERCAREER CENTER

Industry News

3/11/2010

Marquette General to Improve Patient Care across Michigan's Upper Peninsula with McKesson EHR

Portola Pharmaceuticals Announces Senior Management and Board Changes

Leading Varian-Equipped Proton Therapy Center Treats 100th Patient

FDA Grants Orphan Drug Status to Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis

Hana Biosciences Appoints Craig W. Carlson as Chief Financial Officer

Agilent Technologies' Fault Detective Test Optimization and Diagnostic Software Delivers Results up to 1,000 Times Faster

Nutracea Completes Sale Of Non-Core Cereal Ingredients Business

3/10/2010

Codexis Names Vonnie Estes To New Technology Strategic Planning VP Role

Cancer Patients in Kent Gain Access to Advanced RapidArc Radiotherapy Treatments from Varian

Peer-Reviewed Published Study Demonstrates Safety of UC-II

Duquesne University, Agilent Technologies Establish Mass Spectrometry Center of Excellence to Study Diseases, Environmental Issues

Vermillion Announces Scientific Advisory Board Appointments

Cytokinetics Announces Orphan Drug Designation Granted to CK-2017357 for the Treatment of Amyotrophic Lateral Sclerosis

3/9/2010

Odyssey Thera announces agreement with Lonza

Biosearch Technologies Expands Licensing of Roche Patents to Manufacture Kits Targeting the in-vitro Diagnostic Industry

Concentric Medical and the Merci Retrieval System Highlighted at the 2010 International Stroke Conference

Ingenuity Systems Announces New Distributor in Taiwan

BioImagene Introduces the iSlide to Enhance the Transition from Manual to Digital Pathology

Solazyme and Unilever Partner to Bring Algal Renewable Oil to Personal Care Products

Newly Published Data Shows Chronix Biomedical's Serum Dna Assays Can Detect Early-Stage Breast Cancer

Bruker and Agilent Technologies Announce Agreement for Bruker to Acquire Certain Varian Inc. Product Lines

Bruker and Agilent Technologies Announce Agreement for Bruker to Acquire Certain Varian Inc. Product Lines

Trading Halted in InterMune Common Stock

FDA Advisory Committee Recommends Approval of InterMune's Esbriet (pirfenidone) for Idiopathic Pulmonary Fibrosis

OVA1 Blood Test Now Available to Aid Pre-surgical Evaluation of Women for Ovarian Cancer

3/8/2010

Entelos and RegeneMed Introduce iToxFX to Help Predict the Safety of New Drugs

Bayer CropScience and Mendel Biotechnology expand collaboration in crop protection

Fluidigm Releases 5KB & 10KB Long Range PCR Protocol Access Array Systems

Patrick Pichette Joins Amyris Board of Directors

Varian Medical Systems Names Dr. John Adler as Chief of New Clinical Applications

VIVUS Announces the Issuances of Three Additional Qnexa Patents

Nektar Announces Positive Phase II Clinical Data from First Stage of NKTR-102 Study in Women with Platinum-Resistant Ovarian Cancer

Exelixis Announces Restructuring

Genomic Health Announces Publication of Study Using Oncotype DX in Node-Negative and Node-Positive Breast Cancer Patients Treated With Aromatase Inhibitors

3/5/2010

McKesson Named "Most Admired" Company Among Healthcare Distributors by FORTUNE Magazine and one of Nation's 100 Best Corporate Citizens by Corporate Responsibility Magazine

Next Generation Dissolution Apparatus From Varian, Inc. Blends Flexibility With Automation

InterMune Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on Pirfenidone

XenoPort Restructures to Focus on Key Programs

3/4/2010

Tecan and ForteBio automate label-free assays for bioprocess and drug discovery applications

BioImagene Supports University of Miami's Relief Program in Haiti with Digital Pathology Solutions

Varian Medical Systems to Highlight Leading Solutions for Digital X-Ray Imaging at the ECR Annual Meeting

bioTheranostics Announces Commercial Availability of Expanded Tumor-Type Database for CancerTYPE ID and the Launch of KRAS Testing

BayBio 400 Oyster Point Blvd. Suite 221 South San Francisco CA 94080 Tel: (650) 871-7101